Furthermore, the Cancer Genome Atlas Study of Bladder Cancer 2017, whole-exome sequencing of 412 MIBC detected that BCL9L is mutated in 11 patients out of 412, indicating that BCL9L might have a role in bladder cancer [42]. Here, BCL9L is linked to urinary bladder cancer.